Danielle Kim Turgeon
4 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Phase 1 In-vivo Biliary Study of KSP/QRH Heptapeptide Dimer (NCT04304781) | Danielle Kim Turgeon | 2020-09-22 |
| Gastric Gluten-Degradation Activity of PvP001 (NCT03594331) | Danielle Kim Turgeon | 2018-05-25 |
Track Danielle Kim Turgeon automatically
Every clearance here is in the API, with alerts when new ones post.